CRISPR / CAS9 system - a tool for studying hereditary cardiovascular diseases

The search for more effective and safe drugs for cardiovascular diseases is one of the most urgent tasks of experimental cardiology and pharmacology. In the case of hereditary diseases of the cardiovascular system, particularly difficult is the search for the genes responsible for disease development and decoding of their interactions in the process of developing the disease. In addition, the current challenge is to identify genome single nucleotide polymorphisms that affect the degree of manifestation of disease. In recent years, rapidly developing areas related to the use of genome editing systems such as CRISPR/Cas9. CRISPR/ Cas9 system is a convenient and relatively easy-to-use tool that can effectively contribute towards changes in the genomes of cultured human cells, to carry out the knockout genes control their transcription, make or correct gene mutations. In this review, an analysis of the latest advances in the use of CRISPR/Cas9 for research and treatment of diseases, and describes the prospects for its use for the study of cardiovascular disease and the search for new methods for their treatment.